Mkts

ANI Pharmaceuticals, Inc.

NASDAQ: ANIP
$72.61-1.14 (-1.55%)
As of Oct 23, 4:00 PM ET

Key statistics

Day range
72.0573.42
52-week range
69.5897.00
Today
Open73.30
Previous close72.61
Volume—
Valuation
Market cap1.67B
P/E ratio15.40×
EPS (TTM)5.00
Income & risk
Dividend / yield—
Beta0.47
Avg volume366.4K
Discussion

ANIP News

Stories mentioning ANIP from around the web — every one is an open thread, so give it a like or add your take.

All news →

Loading news…

Financial statements

Financial statements

As filed, straight from the 10-Q — up to 19 years of history, free, with every line item chartable.

Line itemQ1 '26Mar 31Q4 '25Dec 31Q3 '25Sep 30Q2 '25Jun 30Q1 '25Mar 31Q4 '24Dec 31Q3 '24Sep 30Q2 '24Jun 30
Income Statement
Revenue237,462247,060227,813211,371197,122190,574148,332138,040
Cost of Goods Sold
Gross Profit
Operating Expenses
Research & Development10,60012,26112,30416,53510,56416,64610,1287,296
Sales General & Admin73,65582,79076,65681,77176,52869,71979,07552,821
Total Operating Expenses
Operating Income (Loss)38,88834,76736,24013,89226,194(4,378)(20,519)5,169
Interest Income
Interest Expense
Other Expense(651.00)850.00(853.00)1,739198.00(1,378)(2,535)(88.00)
Pretax Income40,22131,47933,80010,52519,987(13,762)(31,498)(2,287)
Tax Provision10,7293,9897,1831,9764,306(3,486)(7,332)0.00
Net Income (Loss)29,49227,49026,6178,54915,681(10,276)(24,166)(2,287)
Earnings Per Share (Basic)1.311.371.190.370.70(0.53)(1.27)(0.14)
Earnings Per Share (Diluted)1.281.291.130.360.69(0.53)(1.27)(0.14)
Weighted Average Shares Outstanding (Basic)20,91420,05320,07419,83419,60719,31819,40419,321
Weighted Average Shares Outstanding (Diluted)21,54421,22821,09320,30820,04619,31819,40419,321

Scroll the table sideways for older periods — the line-item column and the period header stay put. Hover a row and use the chart handle to plot it over the full history.

Key facts

About ANIP

ANI Pharmaceuticals, Inc. (NASDAQ: ANIP) is a stock listed on the Nasdaq Stock Market under the ticker symbol ANIP. It last traded at $72.61 (Oct 23, 2026, 4:00 PM ET), down 1.6% on the day. That gives ANI Pharmaceuticals a market capitalisation of $1.7B and a price-to-earnings ratio of 15.4.

Over the past 52 weeks ANIP has traded between $69.58 and $97.00.

Revenue for the quarter ended Mar 31, 2026 was $237.5M; net income $29.5M. Revenue was up 20.5% from $197.1M in the quarter ended Mar 31, 2025.

Last 4 quarters
Quarter endedRevenueNet incomeMargin
Mar 31, 2026$237.5M$29.5M12.4%
Dec 31, 2025$247.1M$27.5M11.1%
Sep 30, 2025$227.8M$26.6M11.7%
Jun 30, 2025$211.4M$8.5M4.0%

From ANI Pharmaceuticals’s quarterly (10-Q) filings, in US dollars.

Latest News

Market news from around the web — every story is an open thread, so give it a like or add your take.

All news →

Loading news…